NEW YORK (Reuters) – A $117 million verdict against Johnson & Johnson and a supplier in favor of a man who said his asbestos-related cancer was caused by long-term use of J&J’s Baby Powder could open a new front for thousands of cases claiming the widely-used product caused cancer, legal experts and plaintiffs lawyers said.
Source: Reuters Medical News
(Reuters) – Apricus Biosciences Inc said on Monday it was considering options for the company and looking to sell the U.S. rights to its erectile dysfunction cream Vitaros, after the Food and Drug Administration asked it to make a new formula for the product.
Source: Reuters Medical News
ZURICH (Reuters) – Swiss fragrance and flavors company Givaudan has begun recycling Haitian vetiver roots now used to make oil for fragrances to produce a new cosmetic substance it said can reduce wrinkles and help scents linger longer.
Source: Reuters Medical News
| Trials using nasal spray esketamine showed rapid improvement in depressive symptoms
Related items from OnMedica Management of depression: non-pharmacological |
Source: OnMedica
| And survey reveals many staff consider seeking work outside the NHS
Related items from OnMedica Chemo treatment ‘unsustainable’ due to staff shortages |
Source: OnMedica
| RCGP says current agreement ‘treats GP patient data like the Yellow Pages’
Related items from OnMedica Increase in health charge paid by temporary migrants |
Source: OnMedica
| People with learning difficulties and dementia among 350,000 who could benefit
Related items from OnMedica Patients spend money better than GPs, report suggests |
Source: OnMedica
| Doctors hope the discovery will lead to potential new treatments
Related items from OnMedica Antidepressant link to persistent pulmonary hypertension |
Source: OnMedica
(Reuters) – Nearly 207 million eggs from a farm in North Carolina are being recalled from nine U.S. states after 22 people fell ill, the federal Food and Drug Administration has said.
Source: Reuters Medical News
NEW YORK (Reuters) – Mylan N.V.’s emergency allergy antidote EpiPen is in short supply in Canada and Britain, but remains available in the United States, the treatment’s manufacturer said on Friday.
Source: Reuters Medical News